Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 49, 2020 - Issue 1
Submit an article Journal homepage
204
Views
15
CrossRef citations to date
0
Altmetric
Short Communications

Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease

C DavidDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, FranceCorrespondence[email protected]
,
G DivardDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
,
R AbbasDepartment of Epidemiology and Clinical Research, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
,
B EscoubetDepartement of Physiology, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, INSERM, Paris, France
,
J ChezelDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
,
MP ChauveheidDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
,
D RouzaudDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
,
A BouttenDepartment of Metabolic and Cellular Biochemistry, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
,
T PapoDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France;INSERM U1149 (French Institute of Health and Medical Research), University of Paris Diderot, Paris, France;Hospital-University Department of Fibrosis, Inflammation and Remodelling in Renal and Respiratory Diseases, FIRE, Paris, France
,
M DehouxDepartment of Metabolic and Cellular Biochemistry, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France
&
K SacreDepartement of Internal Medicine, Bichat Hospital, University of Paris Diderot, PRES Sorbonne Paris Cité, APHP, Public Hospitals of Paris, Paris, France;INSERM U1149 (French Institute of Health and Medical Research), University of Paris Diderot, Paris, France;Hospital-University Department of Fibrosis, Inflammation and Remodelling in Renal and Respiratory Diseases, FIRE, Paris, France
 show all
Pages 33-37 | Accepted 31 Mar 2019, Published online: 04 Jun 2019

References

  • Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harle JR, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol 2014;66:2503–11.
  • Sacre K, Escoubet B, Zennaro MC, Chauveheid MP, Gayat E, Papo T. Overweight is a major contributor to atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease: a cross-sectional controlled study. Medicine (Baltimore) 2015;94:e2177.
  • Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331–7.
  • Divard G, Abbas R, Chenevier-Gobeaux C, Chanson N, Escoubet B, Chauveheid MP, et al. High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study. Arthritis Res Ther 2017;19:132.
  • McMahon M, Skaggs BJ, Grossman JM, Sahakian L, Fitzgerald J, Wong WK, et al. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol 2014;66:130–9.
  • Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, et al. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis. Nephrol Dial Transplant 2016;31:2023–33.
  • Guo L, Akahori H, Harari E, Smith SL, Polavarapu R, Karmali V, et al. CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis. J Clin Invest 2018;128:1106–24.
  • Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, et al. Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men. J Infect Dis 2017;215:1352–61.
  • Aristoteli LP, Moller HJ, Bailey B, Moestrup SK, Kritharides L. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis 2006;184:342–7.
  • Weaver LK, Hintz-Goldstein KA, Pioli PA, Wardwell K, Qureshi N, Vogel SN, et al. Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol 2006;80:26–35.
  • Clement M, Charles N, Escoubet B, Guedj K, Chauveheid MP, Caligiuri G, et al. CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus. J Autoimmun 2015;63:59–67.
  • Platt N, Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse’s tale. J Clin Invest 2001;108:649–54.
  • Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 2006;4:211–21.
  • Hogger P, Dreier J, Droste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998;161:1883–90.
  • Kao AH, Lertratanakul A, Elliott JR, Sattar A, Santelices L, Shaw P, et al. Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus. Am J Cardiol 2013;112:1025–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.